Additionally, chronic administration of the NOD2 ligand MDP either prior to the development of disease (preventatively) or after development of insulin resistance (therapeutically) resulted in improved insulin sensitivity and glucose tolerance in HFD fed wildtype mice [23]. This evidence concerns the gene NOD2 and Insulin resistance.